-
Neoadjuvant treatment in 2025 | 2 hr 8 min 1
Following recent PBS listings of neoadjuvant regimens for Stage III melanoma in Australia, there is an urgent need for practical, real-world guidance on how to implement these therapies effectively within multidisciplinary care.
Chaired by Professor Georgina Long AO and featuring world-leading multidisciplinary experts, this recording from MIA’s live-streamed symposium will provide you with practical, case-based insights into patient and treatment selection, multidisciplinary coordination and response assessment — equipping clinicians to deliver this new standard of care — and will highlight upcoming research efforts to further improve outcomes for patients.
This session was recorded at MIA’s Specialists’ Symposium: Neoadjuvant Treatment in 2025 and is designed for Medical Oncologists, Surgeons, Pathologists, Dermatologists, Radiation Oncologists and relevant Trainees, and may also be suitable for other healthcare professionals.
A Statement of Completion will be provided for your own CPD records. Please click FINISH after viewing the recording.
CO-CHAIRs
Prof Georgina Long AO
Medical Oncologist and Medical Director, Melanoma Institute Australia, The University of Sydney and Royal North Shore Hospital
Declaration of Interest
A/Prof Ines Silva
Medical Oncologist, Melanoma Institute Australia
Declaration of Interest
PRESENTERS AND PANELLISTS
A/Prof Alexander Menzies
Medical Oncologist, Melanoma Institute Australia and Royal North Shore and Mater Hospitals | Associate Professor of Melanoma Medical Oncology, The University of Sydney
Declaration of Interest
Prof Alexander van Akkooi
Associate Professor in Melanoma Surgical Oncology, Melanoma Institute Australia and Royal Prince Alfred Hospital, The University of Sydney
Declaration of Interest
Dr Robert Rawson
Pathologist, Melanoma Institute Australia |Tissue Pathology Staff Specialist, Royal Prince Alfred Hospital
Declaration of Interest
Prof Angela Hong
Radiation Oncologist and Deputy Medical Director, Melanoma Institute Australia | Clinical Professor, The University of Sydney
A/Prof Matteo Carlino
Medical Oncologist, Melanoma Institute Australia and Westmead Hospital
Declaration of Interest
Dr Thomas Pennington Surgical Oncologist, Melanoma Institute Australia Royal Prince Alfred Hospital and Northern Beaches Hospital Senior Clinical Lecturer, The University of Sydney Declaration of Interest
Aled Gaynor
Clinical Nurse Consultant, Melanoma Institute Australia
Declaration of Interest
Please note that this presentation was accurate at the time of recording (Nov 2025) but may not reflect the rapidly evolving treatment landscape and approvals in Australia.
This dinner meeting was an initiative of Melanoma Institute Australia and was proudly sponsored by:
-
Neoadjuvant symposium | 2 hr 8 minModule1.102 hour 08 min
-
